Annual EBITDA
-$18.65 M
+$12.22 M+39.58%
December 31, 2023
Summary
- As of February 8, 2025, AWH annual EBITDA is -$18.65 million, with the most recent change of +$12.22 million (+39.58%) on December 31, 2023.
- During the last 3 years, AWH annual EBITDA has fallen by -$937.00 thousand (-5.29%).
- AWH annual EBITDA is now -228.28% below its all-time high of -$5.68 million, reached on December 31, 1999.
Performance
AWH EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$3.52 M
+$848.00 K+19.42%
September 30, 2024
Summary
- As of February 8, 2025, AWH quarterly EBITDA is -$3.52 million, with the most recent change of +$848.00 thousand (+19.42%) on September 30, 2024.
- Over the past year, AWH quarterly EBITDA has increased by +$557.00 thousand (+13.67%).
- AWH quarterly EBITDA is now -195.63% below its all-time high of $3.68 million, reached on December 31, 2000.
Performance
AWH Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$16.66 M
+$557.00 K+3.23%
September 30, 2024
Summary
- As of February 8, 2025, AWH TTM EBITDA is -$16.66 million, with the most recent change of +$557.00 thousand (+3.23%) on September 30, 2024.
- Over the past year, AWH TTM EBITDA has increased by +$3.67 million (+18.07%).
- AWH TTM EBITDA is now -557.70% below its all-time high of $3.64 million, reached on June 30, 2000.
Performance
AWH TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
AWH EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +39.6% | +13.7% | +18.1% |
| 3 y3 years | -5.3% | +13.7% | +18.1% |
| 5 y5 years | -75.0% | +13.7% | +18.1% |
AWH EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +42.2% | at high | +61.7% | at high | +53.5% |
| 5 y | 5-year | -24.8% | +42.2% | -5.1% | +63.4% | -13.8% | +53.5% |
| alltime | all time | -228.3% | +42.2% | -195.6% | +74.3% | -557.7% | +53.5% |
Aspira Womens Health EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$3.52 M(-19.4%) | -$16.66 M(-3.2%) |
| Jun 2024 | - | -$4.37 M(-6.7%) | -$17.22 M(+0.6%) |
| Mar 2024 | - | -$4.68 M(+14.2%) | -$17.12 M(-8.2%) |
| Dec 2023 | -$18.65 M(-39.6%) | -$4.10 M(+0.5%) | -$18.65 M(-8.3%) |
| Sep 2023 | - | -$4.08 M(-4.5%) | -$20.34 M(-17.9%) |
| Jun 2023 | - | -$4.27 M(-31.3%) | -$24.78 M(-13.6%) |
| Mar 2023 | - | -$6.21 M(+7.3%) | -$28.66 M(-9.4%) |
| Dec 2022 | -$30.87 M(-4.4%) | -$5.79 M(-32.0%) | -$31.64 M(-8.9%) |
| Sep 2022 | - | -$8.51 M(+4.4%) | -$34.73 M(-3.1%) |
| Jun 2022 | - | -$8.16 M(-11.2%) | -$35.85 M(+0.5%) |
| Mar 2022 | - | -$9.18 M(+3.4%) | -$35.68 M(+10.5%) |
| Dec 2021 | -$32.29 M(+82.3%) | -$8.88 M(-7.7%) | -$32.30 M(+9.8%) |
| Sep 2021 | - | -$9.63 M(+20.5%) | -$29.41 M(+22.5%) |
| Jun 2021 | - | -$7.99 M(+37.6%) | -$24.00 M(+21.3%) |
| Mar 2021 | - | -$5.81 M(-3.0%) | -$19.78 M(+11.6%) |
| Dec 2020 | -$17.72 M(+18.5%) | -$5.99 M(+42.0%) | -$17.72 M(+17.5%) |
| Sep 2020 | - | -$4.22 M(+11.9%) | -$15.08 M(+2.9%) |
| Jun 2020 | - | -$3.77 M(+0.6%) | -$14.65 M(-3.0%) |
| Mar 2020 | - | -$3.74 M(+11.9%) | -$15.09 M(+1.0%) |
| Dec 2019 | -$14.95 M(+40.2%) | -$3.35 M(-11.7%) | -$14.95 M(+4.7%) |
| Sep 2019 | - | -$3.79 M(-10.1%) | -$14.27 M(+10.0%) |
| Jun 2019 | - | -$4.21 M(+17.2%) | -$12.97 M(+11.8%) |
| Mar 2019 | - | -$3.60 M(+34.3%) | -$11.60 M(+8.9%) |
| Dec 2018 | -$10.66 M(+10.4%) | -$2.68 M(+7.6%) | -$10.66 M(-0.7%) |
| Sep 2018 | - | -$2.49 M(-12.7%) | -$10.73 M(+1.8%) |
| Jun 2018 | - | -$2.85 M(+7.5%) | -$10.55 M(+7.1%) |
| Mar 2018 | - | -$2.65 M(-3.8%) | -$9.85 M(+2.0%) |
| Dec 2017 | -$9.65 M(-32.2%) | -$2.75 M(+19.6%) | -$9.65 M(+1.3%) |
| Sep 2017 | - | -$2.30 M(+7.2%) | -$9.53 M(-9.2%) |
| Jun 2017 | - | -$2.15 M(-12.5%) | -$10.50 M(-12.0%) |
| Mar 2017 | - | -$2.45 M(-6.8%) | -$11.94 M(-16.1%) |
| Dec 2016 | -$14.23 M(-24.9%) | -$2.63 M(-19.4%) | -$14.23 M(-13.8%) |
| Sep 2016 | - | -$3.27 M(-8.9%) | -$16.50 M(-9.8%) |
| Jun 2016 | - | -$3.58 M(-24.5%) | -$18.30 M(-6.2%) |
| Mar 2016 | - | -$4.75 M(-3.1%) | -$19.50 M(+2.8%) |
| Dec 2015 | -$18.96 M(-0.6%) | -$4.90 M(-3.1%) | -$18.96 M(+4.9%) |
| Sep 2015 | - | -$5.06 M(+5.7%) | -$18.08 M(-2.7%) |
| Jun 2015 | - | -$4.79 M(+13.8%) | -$18.57 M(-3.8%) |
| Mar 2015 | - | -$4.21 M(+4.7%) | -$19.31 M(+1.3%) |
| Dec 2014 | -$19.07 M(+116.9%) | -$4.02 M(-27.6%) | -$19.07 M(+13.1%) |
| Sep 2014 | - | -$5.55 M(+0.5%) | -$16.86 M(+23.9%) |
| Jun 2014 | - | -$5.53 M(+39.3%) | -$13.60 M(+33.7%) |
| Mar 2014 | - | -$3.97 M(+119.5%) | -$10.18 M(+15.8%) |
| Dec 2013 | -$8.79 M(+28.3%) | -$1.81 M(-21.4%) | -$8.79 M(+5.6%) |
| Sep 2013 | - | -$2.30 M(+9.5%) | -$8.33 M(+4.6%) |
| Jun 2013 | - | -$2.10 M(-18.6%) | -$7.96 M(+2.8%) |
| Mar 2013 | - | -$2.58 M(+92.0%) | -$7.75 M(+13.0%) |
| Dec 2012 | -$6.85 M | -$1.34 M(-30.5%) | -$6.85 M(-19.9%) |
| Sep 2012 | - | -$1.93 M(+2.4%) | -$8.56 M(-23.3%) |
| Jun 2012 | - | -$1.89 M(+11.7%) | -$11.15 M(-24.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | -$1.69 M(-44.5%) | -$14.85 M(-14.3%) |
| Dec 2011 | -$17.32 M(-6.0%) | -$3.05 M(-32.7%) | -$17.32 M(-4.6%) |
| Sep 2011 | - | -$4.53 M(-18.8%) | -$18.16 M(+11.9%) |
| Jun 2011 | - | -$5.58 M(+34.1%) | -$16.23 M(+45.0%) |
| Mar 2011 | - | -$4.16 M(+7.0%) | -$11.19 M(-39.3%) |
| Dec 2010 | -$18.43 M(-7.9%) | -$3.89 M(+49.3%) | -$18.43 M(-10.5%) |
| Sep 2010 | - | -$2.60 M(+381.3%) | -$20.59 M(-27.7%) |
| Jun 2010 | - | -$541.00 K(-95.3%) | -$28.48 M(-2.4%) |
| Mar 2010 | - | -$11.40 M(+88.6%) | -$29.18 M(+45.8%) |
| Dec 2009 | -$20.01 M(+29.9%) | -$6.04 M(-42.4%) | -$20.01 M(+13.4%) |
| Sep 2009 | - | -$10.50 M(+743.7%) | -$17.65 M(+57.8%) |
| Jun 2009 | - | -$1.24 M(-44.1%) | -$11.18 M(-17.7%) |
| Mar 2009 | - | -$2.23 M(-39.5%) | -$13.59 M(-11.8%) |
| Dec 2008 | -$15.41 M(-12.6%) | -$3.68 M(-8.8%) | -$15.41 M(+9.1%) |
| Sep 2008 | - | -$4.03 M(+10.4%) | -$14.13 M(-2.7%) |
| Jun 2008 | - | -$3.65 M(-9.7%) | -$14.52 M(-11.3%) |
| Mar 2008 | - | -$4.04 M(+68.7%) | -$16.37 M(-7.2%) |
| Dec 2007 | -$17.64 M(+26.0%) | -$2.40 M(-45.8%) | -$17.64 M(+20.4%) |
| Sep 2007 | - | -$4.42 M(-19.7%) | -$14.65 M(-4.7%) |
| Jun 2007 | - | -$5.51 M(+3.8%) | -$15.37 M(-2.0%) |
| Mar 2007 | - | -$5.31 M(-999.7%) | -$15.69 M(+12.1%) |
| Dec 2006 | -$13.99 M(-50.3%) | $590.00 K(-111.5%) | -$13.99 M(-38.3%) |
| Sep 2006 | - | -$5.14 M(-11.8%) | -$22.66 M(-2.2%) |
| Jun 2006 | - | -$5.83 M(+61.1%) | -$23.17 M(-6.0%) |
| Mar 2006 | - | -$3.62 M(-55.3%) | -$24.64 M(-12.4%) |
| Dec 2005 | -$28.14 M(+4.7%) | -$8.08 M(+43.2%) | -$28.14 M(+10.7%) |
| Sep 2005 | - | -$5.64 M(-22.7%) | -$25.41 M(-4.3%) |
| Jun 2005 | - | -$7.30 M(+2.7%) | -$26.56 M(-11.1%) |
| Mar 2005 | - | -$7.11 M(+32.9%) | -$29.89 M(+10.9%) |
| Dec 2004 | -$26.87 M(-9.1%) | -$5.35 M(-21.3%) | -$26.95 M(+1.3%) |
| Sep 2004 | - | -$6.80 M(-36.0%) | -$26.60 M(+16.5%) |
| Jun 2004 | - | -$10.63 M(+154.2%) | -$22.83 M(-11.8%) |
| Mar 2004 | - | -$4.18 M(-16.3%) | -$25.89 M(-12.4%) |
| Dec 2003 | -$29.56 M(+13.0%) | -$5.00 M(+64.6%) | -$29.56 M(-5.6%) |
| Sep 2003 | - | -$3.03 M(-77.8%) | -$31.32 M(-10.5%) |
| Jun 2003 | - | -$13.68 M(+74.4%) | -$35.00 M(+26.1%) |
| Mar 2003 | - | -$7.85 M(+16.1%) | -$27.75 M(+7.4%) |
| Dec 2002 | -$26.15 M(+18.5%) | -$6.76 M(+0.6%) | -$25.85 M(+5.9%) |
| Sep 2002 | - | -$6.71 M(+4.3%) | -$24.40 M(+2.9%) |
| Jun 2002 | - | -$6.43 M(+8.2%) | -$23.72 M(+4.8%) |
| Mar 2002 | - | -$5.95 M(+12.0%) | -$22.62 M(+2.5%) |
| Dec 2001 | -$22.06 M(+83.1%) | -$5.31 M(-12.0%) | -$22.06 M(+68.7%) |
| Sep 2001 | - | -$6.03 M(+13.0%) | -$13.07 M(-1.6%) |
| Jun 2001 | - | -$5.34 M(-0.9%) | -$13.28 M(+116.9%) |
| Mar 2001 | - | -$5.39 M(-246.4%) | -$6.13 M(-666.1%) |
| Dec 2000 | -$12.05 M(+112.1%) | $3.68 M(-159.0%) | $1.08 M(-141.6%) |
| Sep 2000 | - | -$6.24 M(-442.6%) | -$2.60 M(-171.4%) |
| Jun 2000 | - | $1.82 M(+0.1%) | $3.64 M(+100.1%) |
| Mar 2000 | - | $1.82 M | $1.82 M |
| Dec 1999 | -$5.68 M(-17.3%) | - | - |
| Dec 1998 | -$6.87 M | - | - |
FAQ
- What is Aspira Womens Health annual EBITDA?
- What is the all time high annual EBITDA for Aspira Womens Health?
- What is Aspira Womens Health annual EBITDA year-on-year change?
- What is Aspira Womens Health quarterly EBITDA?
- What is the all time high quarterly EBITDA for Aspira Womens Health?
- What is Aspira Womens Health quarterly EBITDA year-on-year change?
- What is Aspira Womens Health TTM EBITDA?
- What is the all time high TTM EBITDA for Aspira Womens Health?
- What is Aspira Womens Health TTM EBITDA year-on-year change?
What is Aspira Womens Health annual EBITDA?
The current annual EBITDA of AWH is -$18.65 M
What is the all time high annual EBITDA for Aspira Womens Health?
Aspira Womens Health all-time high annual EBITDA is -$5.68 M
What is Aspira Womens Health annual EBITDA year-on-year change?
Over the past year, AWH annual EBITDA has changed by +$12.22 M (+39.58%)
What is Aspira Womens Health quarterly EBITDA?
The current quarterly EBITDA of AWH is -$3.52 M
What is the all time high quarterly EBITDA for Aspira Womens Health?
Aspira Womens Health all-time high quarterly EBITDA is $3.68 M
What is Aspira Womens Health quarterly EBITDA year-on-year change?
Over the past year, AWH quarterly EBITDA has changed by +$557.00 K (+13.67%)
What is Aspira Womens Health TTM EBITDA?
The current TTM EBITDA of AWH is -$16.66 M
What is the all time high TTM EBITDA for Aspira Womens Health?
Aspira Womens Health all-time high TTM EBITDA is $3.64 M
What is Aspira Womens Health TTM EBITDA year-on-year change?
Over the past year, AWH TTM EBITDA has changed by +$3.67 M (+18.07%)